Introduction: ToF patients are at risk for ventricular deterioration at a relatively young age, which can be aggravated by AF development. Therefore, knowledge on AF development and its timespan of progression is essential to guide treatment strategies for AF.
INTRODUCTION
Tetralogy of Fallot (ToF) is the most prevalent cyanotic congenital heart disease (CHD); 1 approximately 4% of all patients with CHD are diagnosed with ToF. 2 As a result of improved medical care and advances in surgical techniques since the 1950s, more than 85% of the ToF patients nowadays survive into adulthood. 1 However, new challenges arose since long-term complications, such as tachyarrhythmias, became more prevalent. In the registry of the This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. Alliance for Adult Research in Congenital Cardiology (AARCC), up to 43% of the 556 ToF patients had tachyarrhythmias. 3 In previous studies, ventricular tachyarrhythmias (VTA) with potentially devastating consequences were frequently observed. 4, 5 However, the prevalence of supraventricular tachyarrhythmias (SVT) is also considerably high. 6, 7 SVT were present in 20% of the patients included in the AARCC registry; intra-atrial reentrant tachyarrhythmias (IART) were most prevalent (12%) whereas 7% had atrial fibrillation (AF).
The incidence of AF increases with age and is more prevalent in ToF patients older than 55 years. The mechanism underlying AF development in ToF patients is unknown. Previous studies identified palliative shunting prior to total ToF correction as a predictor for SVT and AF. 6 Also, it was suggested that regular SVT might facilitate development of AF in CHD patients. 8 Due to multiple surgical procedures and often long-term pressure and volume overload, ToF patients are at risk for ventricular deterioration at a relatively young age, which can be aggravated by AF development. [9] [10] [11] Therefore, particularly in ToF patients, knowledge on AF development and its timespan of progression is essential to guide treatment strategies for AF. Individualized AF therapy may thereby contribute to maximal preservation of ventricular function in these patients.
The aims of this study were to examine (1) onset of AF in a cohort of patients who underwent total ToF correction in relation to clinical profiles and (2) progression of late, postoperative AF in ToF patients during long-term follow-up.
METHODS
This retrospective longitudinal study was part of the "DysrhythmiAs in patieNts with congenitAl heaRt diseAse" (DANARA) project (MEC-2012-482) and was approved by the local ethics committee in the Erasmus University Medical Center Rotterdam. Informed consent was not obliged.
Study population
All corrected ToF patients with documented AF episodes referred to the electrophysiology department between 2000 and 2015 were included in this study (N = 29); patients with pulmonary atresia were excluded. Data on demographics and clinical characteristics including, echocardiograms, cardiac surgery, prescribed antiarrhythmic drugs (AAD), outcomes of electrocardioversions (ECV) or death were retrieved from the patient medical records.
Clinical data
All rhythm registrations collected during routine visits at the outpatient clinic, hospitalization, or at the emergency room including electrocardiograms (ECG), 24-hour Holter registrations and device print outs were reviewed for episodes of AF or regular SVT.
An irregular rhythm combined with a clear beat-to-beat variation in the morphology of atrial waves was considered as AF. AF was categorized as paroxysmal, persistent or permanent AF according to the ESC guidelines for the management of AF. 12 The investigators did not differentiate between a typical (counter) clockwise atrial flutter, IART or ectopic atrial tachycardia, as differentiation between these types of SVT cannot always be made based on the surface ECG only. AF progression was defined as transition from paroxysmal AF to (longstanding) persistent/permanent AF or from (longstanding) persistent AF to permanent AF. In addition to the occurrence of AF and regular SVT, rhythm registrations were also reviewed for occurrence of VTA, including nonsustained and sustained ventricular tachycardia (nsVT, sVT) and ventricular fibrillation (VF). 
Statistical analysis
Normally distributed continuous variables were expressed as mean ± standard deviation; skewed data were presented as median (minimummaximum 
RESULTS

Study population
The study population consisted of 29 ToF patients (18 male). As shown in Table 1 
Onset of atrial fibrillation
The upper panel of Figure 1 illustrates age at first AF episode for each patient individually; patients are ranked according to the age of AF onset. Onset of AF occurred at a mean age of 44 ± 12 (25-72) years, which was 28 ± 14 years after total ToF correction. In 1 patient, AF occurred 47 years after palliative shunting, yet before undergoing total ToF correction.
As shown in the lower panels of Figure 1 , age at first AF episode tended to decrease in more recent decades, yet this did not reach Severe dysfunction 7 (24) a Missing clinical data: QRS duration (4), RA dilation (3), RVF (4), cardiac MRI RVEDV (14) . RA = right atrium; RVF = right ventricular function; MRI = magnetic resonance imaging; RVEDV = right ventricular end-diastolic volume.
statistical significance (P = 0.063). Time interval from total ToF onset to first AF episode, however, was significantly shorter in more recent decades of surgical management (P = 0.005).
The first AF episode was paroxysmal (N = 14, 48%), persistent (N = 13, 45%) or permanent (N = 2, 7%); therapy consisted of only rate control in 2 patients presenting with persistent AF and they were therefore labeled as having permanent AF.
We subdivided the study population into two groups; patient who underwent prior palliative shunting followed by total ToF correction and patients who underwent primary total ToF correction.
At first presentation of AF, the incidence of RA dilation did not differ between patients without and with palliative shunting (N = 9 [64%]
vs. N = 10 [67%], respectively, P = 0.893). Also, no difference was observed in the incidence of moderate or severe RV dysfunction (N = 7, 50% vs. N = 6, 40%, respectively, P = 0.588).
As illustrated in the left panel of Figure 2 , patients who underwent prior palliative shunting developed AF at the same age as patients who underwent initial ToF correction, respectively, at 45 ± 11 (25- 
Coexistence of atrial and ventricular tachyarrhythmias
As shown in the left panel of Figure 3 , coexistence of AF and regular SVT was reported in 18 patients (62%), in whom SVT most often presented prior to AF (N = 13, 76%; 10 ± 12 years prior). In 3 patients, episodes of both regular SVT and AF were documented in the same year. In 2 patients, SVT presented, respectively, 6 and 22 years after onset of AF. A total of 4 patients underwent catheter ablation for SVT.
In 2 patients, SVT ablation was performed, respectively, 1 and 1.6 years prior to AF onset, whereas in the other 2 patients SVT ablation was performed, respectively, 1 and 25 years after the first documented AF episode.
The right panel of Figure 3 
Progression of atrial fibrillation
Treatment of AF and rhythm outcome after long-term follow-up is summarized in Figure 4 ; the study population was subdivided according to the initial type of AF.
The majority of patients with paroxysmal AF (N = 14) were treated with AAD (N = 13, 93%), which was aimed at rhythm control in 7 patients (54%); one patient did not receive any pharmacological treatment. Two patients with paroxysmal AF underwent ECV.
Of the 13 patients with persistent AF, 7 patients (54%) were initially cardioverted, of whom 6 patients (85%) started AAD after ECV.
For the other 6 patients (46%), initial treatment consisted of AAD, after which ECV was performed in 3 patients (50%). Of the 12 patients with persistent AF receiving AAD, treatment with AAD was aimed at rhythm control in 8 patients (67%). Two patients presented with permanent AF, as only rate control therapy was initiated and no attempts to cardioversion were performed. None of the patients underwent pulmonary vein isolation or his bundle ablation.
Progression of AF was observed in 11 patients (38%), which 
Mortality
Follow-up time from first AF episode was 11 ± 9 (1-39) years. A total of 10 patients (35%) died at a mean age of 56 ± 11 (33-75) years and 9 ± 8 (1-27)years after AF onset. Nine patients died due to end stage heart failure (age 59 ± 8 years) and 1 patient died due to a shooting incident (age 33 years). 
DISCUSSION
This study reports on development and progression of postoperative AF over time in patients with ToF. AF in ToF patients is often a progressive disease at a relatively young age and both rhythm-control and rate-control therapy were equally ineffective in preventing this.
Coexistence of AF with other tachyarrhythmias, including regular SVT or VT was observed in the majority of the study population.
Age of atrial fibrillation onset
A steep rise in the prevalence of AF from the age of 45 years in ToF patients was demonstrated by Khairy et al., which is comparable with the mean age of AF onset in our study population. 3 It is generally assumed that perpetuation of AF is facilitated by areas of intra-atrial conduction delay or dispersion in refractoriness that has been demonstrated in mapping studies in patients without CHD. [13] [14] [15] Prior electrophysiological studies in CHD patients demonstrated that areas of intra-atrial conduction delay or dispersion in refractoriness are also present in patients with complex CHD. 16 In these patients, intra-atrial conduction is impaired by interposition of fibrotic tissue caused by surgical procedures and ongoing pressure or volume overload. 17 In addition, triggered activity might be increased by enhanced atrial wall stress.
Previous studies have identified palliative shunting as a predictor for SVT or AF, 6 yet we did not observe a difference in age at AF onset between patients undergoing prior palliative shunting versus total ToF correction.
In our population, approximately half of the patients underwent prior palliative shunting and were thereby longer exposed to the consequences of their cardiac defect, awaiting total ToF correction.
Although impairment of cardiac function was indeed observed in our study population, prior palliative shunting did not influence incidences of ventricular dysfunction.
At present, the optimal age for ToF correction is between the age of 3 and 6 months old. 18 Our patient population consists of a subset of the patients who were operated on in the early days of cardiac surgery and is actually presenting the long-term present-day complications of corrective surgery for ToF patients operated some decades ago. In our population, total ToF correction was performed on average 40 years ago. Patients who underwent total ToF correction more recently tended to develop AF earlier after corrective surgery, which may be explained by improved and more standardized methods of follow-up and AF detection.
Coexistence of tachyarrhythmias
In more than 60% of the study population, AF coexisted with regular SVT, which is much higher compared to the 33% that was reported in an earlier study with 199 patients with various CHD and AF. 8 VTA coexisted with AF in a considerable number of patients in our study population. A previous study demonstrated that AF might facilitate the onset of VTA. When AF activates the ventricles at a high rate, ventricular refractoriness is shortened, which in turn promotes onset of VTA. 26 Denker et al. described that short-long-short sequences caused by AF, might be proarrhythmic and facilitates VTA onset. 27 Somberg et al. showed that induction of VTA by programmed electrical stimulation in canine ventricles only induced VTA (96%) during AF
and not during sinus rhythm, also supporting the concept that AF facilitates development of VTA. 28 Four patients in this study developed nsVT or sVT prior to AF onset and all OHCA occurred prior to AF development. It is known that long-term hypoxemia in ToF patients, in addition to the ongoing pressure/volume overload, contributes to degeneration of cardiomyocytes and interstitial fibrosis, which in turn give rise to onset of VTA. 29 Development of AF several years after VTA onset may be an indicator of further hemodynamic deterioration.
Progression of atrial fibrillation
In our study population, AF progressed in a considerable number of patients within a short period of time; progression of AF occurred at a mean age of 44 years and only 5 years after the first documented episode. In the European Heart Survey, progression of AF was more frequently observed in patients who presented with AF at an older age. 30 Older age at the moment when patients first present with AF may therefore also influence rate of progression of AF. Also, it has been demonstrated that electrical and structural remodeling contribute to persistence of AF. 31 Chronic atrial stretch caused by either persistent pressure or volume overload in CHD patients may additionally contribute to persistence of electrical and structural remodeling. 32 In CHD patients, substrate mapping of the atria may be of particular interest to establish the pathophysiologic basis of arrhythmias. In ToF patients, the atria are often hyperthrophied and has extensive fibrotic regions enabling multiple reentrant circuits to occur. Often, during ablation, one tachycardia will convert to a different tachycardia indicated by changes in cycle length or patterns of activation. 33 Optimal assessment and treatment of SVT in ToF and other CHD patients therefore requires a stepwise approach to confirm involvement of particular anatomical areas by entrainment and detailed mapping of the reentry circuit and critical isthmus. In ToF patients, commonly identified circuits include the sub-Eustachian isthmus between the tricuspid valve annulus and inferior vena cava and the posterolateral right atrium adjacent to the atriotomy incision. 33 However, when the critical isthmus cannot be defined properly by entrainment and activation mapping, it has been suggested that identifying low voltage areas, indicating extensive atrial scarring and sites of surgical incisions, could be used as an alternative approach. 33 When creating a linear lesion between scar tissue and anatomical obstacles such as valve annuli, SVT may be eliminated. 33 Similar approaches can also be used to treat VT in ToF patients. 34 Often, VT in ToF patients are related to the scar site of the ventriculo- 
Effectiveness of pharmacological therapy
As mentioned previously, almost 40% of our study population showed progression of AF, which was not affected by the usage of class II or III AAD. As class III AAD are aimed at maintaining sinus rhythm, whereas rate control is aimed at reduction of ventricular rate during AF episodes, AF induced remodeling is more likely to occur in patients with only rate control therapy. In patients without CHD, it has been demonstrated that AF episodes induce shortening of the atrial refractory period (ARP) and inversed rate adaptation thereby facilitating perpetuation of AF. 35 In addition, it has been shown that effectiveness of AAD and ECV for paroxysmal AF decreases over time, also indicating that the presence of AF episodes promote development of longerlasting AF episodes and hence progressiveness of AF. 36, 37 Atrial extra systoles in the presence of a shorter ARP makes the patient more vulnerable to induction of AF episodes and hence AF progression.
LIMITATIONS
Our study population came into treatment decades ago according to the surgical strategies of that time. The present day approaches will probably lead to different findings. As the onset of AF was defined as the first documented AF episode on an ECG, 24-hour Holter recording or medical correspondence, earlier, asymptomatic episodes of AF could have been missed. Since our study population was relatively small, larger multicenter studies are necessary to confirm these observations.
CONCLUSIONS
ToF patients in our study population developed AF in the 4th and 
